Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 Expression

This publication has 48 references indexed in Scilit:

• CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
  British Journal of Cancer, 2008
• Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics
  Breast Cancer Research, 2008
• ΔNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck
  The Journal of Pathology, 2007
• Restoration of p53 function leads to tumour regression in vivo
  Nature, 2007
• E6/E7 oncogenes increase and tumor suppressors decrease the proportion of self-renewing neural progenitor cells
  Oncogene, 2006
• An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
  Proceedings of the National Academy of Sciences, 2005
• Prospective identification of tumorigenic breast cancer cells
  Proceedings of the National Academy of Sciences, 2003
• Serial analysis of gene expression in normal p53 null mammary epithelium
  Oncogene, 2002
• p130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53
  Published by Elsevier ,2001
• CD44 is the principal cell surface receptor for hyaluronate
  Cell, 1990